A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
CHANCES
Phase 1 Unknown
27 enrolled
BIO-META
Unknown
10,000 enrolled
Minnelide 101
Phase 1 Unknown
66 enrolled
EPOST MBC
Phase NA Unknown
100 enrolled
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Phase 2 Unknown
65 enrolled
REGOMUNE
Phase 1/2 Unknown
747 enrolled
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Phase 1 Unknown
78 enrolled
MULAN
Phase 2 Unknown
319 enrolled
A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer
Phase 2 Unknown
70 enrolled
SPACE2
Unknown
150 enrolled
TONIC
Phase 2 Unknown
84 enrolled
X7-7
Phase 2 Unknown
200 enrolled
i-GO
Phase 1 Unknown
12 enrolled
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
Unknown
1,354 enrolled
PIONEER
Unknown
1,000 enrolled
CAMELLIA
Phase 3 Unknown
280 enrolled
Guided Imagery & Music in Cancer
Phase NA Unknown
20 enrolled
IMET
Unknown
300 enrolled
FLIPPER
Phase 2 Unknown
189 enrolled
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Phase NA Unknown
175 enrolled
PALPETBIO
Phase 2 Unknown
54 enrolled
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included
Phase 2/3 Unknown
60 enrolled
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer
Phase 2/3 Unknown
60 enrolled
Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
Unknown
50 enrolled
Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
Phase 2 Unknown
90 enrolled
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Phase 1 Unknown
75 enrolled
GIM11-BERGI
Phase 2 Unknown
61 enrolled
AMBRA
Unknown
1,500 enrolled
FUMANCE
Phase 3 Unknown
156 enrolled
FEVEX
Phase 3 Unknown
745 enrolled
Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis
Unknown
100 enrolled
Arbre
Phase 2 Unknown
60 enrolled
Cultured Circulating Tumor Cells in Prostate and Other Cancers
Unknown
220 enrolled
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Phase 1/2 Unknown
50 enrolled
Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
Phase 3 Unknown
Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
Phase 2 Unknown
100 enrolled
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Phase 3 Unknown
1,404 enrolled
METAMARBO
Unknown
50 enrolled
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
Phase 3 Unknown
200 enrolled
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Unknown
30 enrolled
Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer
Phase 2 Unknown
39 enrolled
Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
Phase 2 Unknown
88 enrolled
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Unknown
75 enrolled
Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome
Phase NA Unknown
80 enrolled
Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
Phase 2 Unknown
100 enrolled
Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma
Phase 1/2 Unknown
25 enrolled
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study
Phase 2 Unknown
30 enrolled
Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen
Phase 1/2 Unknown
46 enrolled